Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release

Pharmazie

Volumn 63, Issue 12, 2008, Pages 878-882

  Ying, Xiao Ying ^a   Du, Yong Zhong ^a   Chen, Wan Wei ^a   Yuan, Hong ^a   Hu, Fu Qiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GLUTARALDEHYDE; GLYCEROL STEARATE; NANOPARTICLE; OCTADECYLAMINE; OLEIC ACID; ANTINEOPLASTIC ANTIBIOTIC; CROSS LINKING REAGENT; DRUG CARRIER; LIPID;

ARTICLE; CONTROLLED RELEASE FORMULATION; CROSS LINKING; DRUG FORMULARY; DRUG RELEASE; ENCAPSULATION; PHYSICAL CHEMISTRY; ALGORITHM; CHEMISTRY; DIFFUSION; DRUG FORMULATION; ELECTROCHEMISTRY; PARTICLE SIZE; SOLUBILITY;

ALGORITHMS; ANTIBIOTICS, ANTINEOPLASTIC; CROSS-LINKING REAGENTS; DIFFUSION; DOXORUBICIN; DRUG CARRIERS; DRUG COMPOUNDING; ELECTROCHEMISTRY; GLUTARAL; LIPIDS; NANOPARTICLES; PARTICLE SIZE; SOLUBILITY;

EID: 61449119793     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8162     Document Type: Article

References (20)

1. Coukell AJ, Spencer CM (1997) Polyethylene glycol-liposomal doxorubicin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma. Drugs 53: 520-538.
2. Domb A, Davidson GW, Sanders LM (1990) Diffusion of peptides through hydrogel membranes. J Control Release 14: 133-144.
3. Dvorak M, Kopeckova P, Kopecek J (1999) High-molecular weight HPMA copolymer-adriamycin conjugates. J Control Release 60: 321-332.
4. Gabizon A, Martin F (1997) Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Drugs 54 (Suppl. 4): 15-21.
5. Hoff V, Layard DD, Basa MW (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Int Med 91: 710-717.
6. Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S (2005) Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids and Surf. B: Biointerfaces 45: 167-173.
7. Humberstone AJ, Charman WN (1997) Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 25: 103-128.
8. Jenning V, Thünemann AF, Gohla SH (2000) Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 199: 167-177.
9. Jenning V, Gohla SH (2001) Encapsulation of retinoids in solid lipid nanoparticles (SLN). J Microencapsul 18: 149-158.
10. Keizer HG, Pinedo HM, Schuurhuis GJ, Joenje H (1990) Doxorubicin (adriamycin): a critical review of free radicaldependent mechanisms of cytotoxicity. Pharmacol Ther 47: 219-231.
11. Kwon GS, Suwa S, Yokoyama M, Okano T, Sakurai S, Kataoka K (1994) Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxideaspartate) block copolymer-adriamycin conjugates. J Control Release 29: 17-23.
12. Minko T, Kopeckova P, Kopecek J (2000) Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. Int J Cancer 86: 108-117.
13. Müller RH, Radtke M, Wissing SA (2002a) Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242: 121-128.
14. Müller RH, Radtke M, Wissing SA (2002b) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54 (Suppl.1): S131-155.
15. Stolnik S, Illum L, Davis SS (1995) Long circulation microparticulate drug carriers. Adv Drug Deliv Rev 16: 195-214.
16. Souto EB, Wissing SA, Barbosa CM, Müller RH (2004) Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 278: 71-77.
17. Warren SJ, Kellaway IW (1998) The synthesis and in vitro characterization of the mucoadhesion and swelling of poly(-acrylic acid) hydrogels. Pharm Dev Technol 3: 199-208.
18. Yang SC, Zhu JB, Lu Y, Liang BW, Yang CZ (1999a) Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm Res 16: 751-757.
19. Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ (1999b) Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release 59: 299-307.
20. Yuan H, Wang LL, Du YZ, You J, Hu FQ, Zeng S (2007) Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surf. B: Biointerface 60: 174-179.